ArticleTrials2026

Phase II clinical trial of KCHO-1 for Alzheimer's disease: study protocol for a multicenter, randomized, double-blind, multi-dose, placebo trial.

Joonyoung Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.